Skip to main navigation Skip to search Skip to main content

Practical implications of using real-world evidence (RWE) in comparative effectiveness research: Learnings from IMI-GetReal

  • Amr Makady*
  • , Heather Stegenga
  • , Antonio Ciaglia
  • , Thomas P.A. Debray
  • , Michael Lees
  • , Michael Happich
  • , Bettina Ryll
  • , Keith Abrams
  • , Rob Thwaites
  • , Sarah Garner
  • , Páll Jonsson
  • , Wim Goettsch
  • *Corresponding author for this work
  • National Institute for Health and Care Excellence
  • International Alliance of Patients' Organizations
  • Utrecht University
  • Bristol-Myers Squibb
  • Eli Lilly
  • Melanoma Patient Network Europe
  • Uppsala University
  • University of Leicester
  • Takeda

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

In light of increasing attention towards the use of real-world evidence (RWE) in decision making in recent years, this commentary aims to reflect on the experiences gained in accessing and using RWE for comparative effectiveness research as a part of the Innovative Medicines Initiative GetReal Consortium and discuss their implications for RWE use in decision-making.
Original languageEnglish
Pages (from-to)485-490
Number of pages6
JournalJournal of Comparative Effectiveness Research
Volume6
Issue number6
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Comparative effectiveness research
  • Health technology assessment
  • Non-randomized trials
  • Real-world evidence

Fingerprint

Dive into the research topics of 'Practical implications of using real-world evidence (RWE) in comparative effectiveness research: Learnings from IMI-GetReal'. Together they form a unique fingerprint.

Cite this